Description

Salofalk (mesalazine) Coated Enteric Tablets 500 mg. №100

Ingredients:

Each tablet contains 500 mg of mesalazine.

Dosage:

The usual dose is 2 to 4 tablets taken once daily or as directed by a healthcare provider.

Indications:

Salofalk tablets are indicated for the treatment of mild to moderate ulcerative colitis and Crohn’s disease.

Contraindications:

Do not use Salofalk if you are allergic to mesalazine or any other ingredients in the tablets.

Directions:

Swallow the tablets whole with water. Do not crush or chew them.

Scientific Evidence:

Studies have shown that mesalazine, the active ingredient in Salofalk, is effective in reducing inflammation in the colon and maintaining remission in patients with ulcerative colitis and Crohn’s disease. Research published in the Journal of Crohn’s and Colitis demonstrated the efficacy of mesalazine in inducing and maintaining clinical and endoscopic remission in patients with ulcerative colitis.

Additional Information:

It is important to follow the prescribed dosage and duration of treatment with Salofalk to achieve the best results. Inform your healthcare provider about any other medications you are taking to avoid potential drug interactions.

Salofalk tablets have a special coating that allows them to pass through the stomach unchanged and dissolve in the intestines where the active ingredient is released. This targeted delivery helps to minimize side effects and maximize the therapeutic effects of the medication.